Literature DB >> 16514665

Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia.

Neetu Tyagi1, Alexander V Ovechkin, David Lominadze, Karni S Moshal, Suresh C Tyagi.   

Abstract

An elevated level of homocysteine (Hcy) limits the growth and induces apoptosis. However, the mechanism of Hcy-induced programmed cell death in endothelial cells is largely unknown. We hypothesize that Hcy induces intracellular reactive oxygen species (ROS) production that leads to the loss of transmembrane mitochondrial potential (Deltapsi(m)) accompanied by the release of cytochrome-c from mitochondria. Cytochrome-c release contributes to caspase activation, such as caspase-9, caspase-6, and caspase-3, which results in the degradation of numerous nuclear proteins including poly (ADP-ribose) polymerase (PARP), which subsequently leads to the internucleosomal cleavage of DNA, resulting cell death. In this study, rat heart microvascular endothelial cells (MVEC) were treated with different doses of Hcy at different time intervals. Apoptosis was measured by DNA laddering and transferase-mediated dUTP nick-end labeling (TUNEL) assay. ROS production and MP were determined using fluorescent probes (2,7-dichlorofluorescein (DCFH-DA) and 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethyl-benzamidazolocarbocyanin iodide (JC-1), respectively, by confocal microscopy. Differential gene expression for apoptosis was analyzed by cDNA array. The results showed that Hcy-mediated ROS production preceded the loss of MP, the release of cytochrome-c, and the activation of caspase-9 and -3. Moreover the Hcy treatment resulted in a decrease in Bcl(2)/Bax ratio, evaluated by mRNA levels. Caspase-9 and -3 were activated, causing cleavage of PARP, a hallmark of apoptosis and internucleosomal DNA fragmentation. The cytotoxic effect of Hcy was blocked by using small interfering RNA (siRNA)-mediated suppression of caspase-9 in MVEC. Suppressing the activation of caspase-9 inhibited the activation of caspase -3 and enhanced the cell viability and MP. Our data suggested that Hcy-mediated ROS production promotes endothelial cell death in part by disturbing MP, which results in subsequent release of cytochrome-c and activation of caspase-9 and 3, leading to cell death. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16514665      PMCID: PMC3182486          DOI: 10.1002/jcb.20837

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  44 in total

1.  BAR: An apoptosis regulator at the intersection of caspases and Bcl-2 family proteins.

Authors:  H Zhang; Q Xu; S Krajewski; M Krajewska; Z Xie; S Fuess; S Kitada; K Pawlowski; A Godzik; J C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 2.  Mitochondria and apoptosis.

Authors:  D R Green; J C Reed
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

Review 3.  Caspases: key mediators of apoptosis.

Authors:  N A Thornberry
Journal:  Chem Biol       Date:  1998-05

Review 4.  Caspase-9.

Authors:  K Kuida
Journal:  Int J Biochem Cell Biol       Date:  2000-02       Impact factor: 5.085

Review 5.  Biochemical pathways of caspase activation during apoptosis.

Authors:  I Budihardjo; H Oliver; M Lutter; X Luo; X Wang
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

6.  Ethanol potentiates tumor necrosis factor-alpha cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition.

Authors:  J G Pastorino; J B Hoek
Journal:  Hepatology       Date:  2000-05       Impact factor: 17.425

7.  Characterization of tBid-induced cytochrome c release from mitochondria and liposomes.

Authors:  D Zhai; X Huang; X Han; F Yang
Journal:  FEBS Lett       Date:  2000-04-28       Impact factor: 4.124

8.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis.

Authors:  E H Cheng; M C Wei; S Weiler; R A Flavell; T W Mak; T Lindsten; S J Korsmeyer
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

Review 9.  Emerging roles of caspase-3 in apoptosis.

Authors:  A G Porter; R U Jänicke
Journal:  Cell Death Differ       Date:  1999-02       Impact factor: 15.828

10.  TNF-alpha activates at least two apoptotic signaling cascades.

Authors:  C Sidoti-de Fraisse; V Rincheval; Y Risler; B Mignotte; J L Vayssière
Journal:  Oncogene       Date:  1998-10-01       Impact factor: 9.867

View more
  38 in total

1.  Cardiac specific deletion of N-methyl-d-aspartate receptor 1 ameliorates mtMMP-9 mediated autophagy/mitophagy in hyperhomocysteinemia.

Authors:  Neetu Tyagi; Jonathan C Vacek; Srikanth Givvimani; Utpal Sen; Suresh C Tyagi
Journal:  J Recept Signal Transduct Res       Date:  2010-04       Impact factor: 2.092

2.  Tetrahydrocurcumin ameliorates homocysteinylated cytochrome-c mediated autophagy in hyperhomocysteinemia mice after cerebral ischemia.

Authors:  Neetu Tyagi; Natia Qipshidze; Charu Munjal; Jonathan C Vacek; Naira Metreveli; Srikanth Givvimani; Suresh C Tyagi
Journal:  J Mol Neurosci       Date:  2012-01-03       Impact factor: 3.444

3.  Tetrahydrocurcumin ameliorates homocysteine-mediated mitochondrial remodeling in brain endothelial cells.

Authors:  Jonathan C Vacek; Jyotirmaya Behera; Akash K George; Pradip K Kamat; Anuradha Kalani; Neetu Tyagi
Journal:  J Cell Physiol       Date:  2017-11-14       Impact factor: 6.384

Review 4.  Endothelial Cell Metabolism.

Authors:  Guy Eelen; Pauline de Zeeuw; Lucas Treps; Ulrike Harjes; Brian W Wong; Peter Carmeliet
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 5.  Mechanisms of cardiovascular remodeling in hyperhomocysteinemia.

Authors:  Mesia M Steed; Suresh C Tyagi
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

6.  Synergism between arrhythmia and hyperhomo-cysteinemia in structural heart disease.

Authors:  Srikanth Givvimani; Natia Qipshidze; Neetu Tyagi; Paras K Mishra; Utpal Sen; Suresh C Tyagi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-05-29

7.  Differential expression of gamma-aminobutyric acid receptor A (GABA(A)) and effects of homocysteine.

Authors:  Neetu Tyagi; David Lominadze; William Gillespie; Karni S Moshal; Utpal Sen; Dorothea S Rosenberger; Mesia Steed; Suresh C Tyagi
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

Review 8.  The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis.

Authors:  Paolo Puddu; Giovanni M Puddu; Eleonora Cravero; Susanna De Pascalis; Antonio Muscari
Journal:  J Biomed Sci       Date:  2009-12-09       Impact factor: 8.410

9.  Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance.

Authors:  Utpal Sen; Walter E Rodriguez; Neetu Tyagi; Munish Kumar; Soumi Kundu; Suresh C Tyagi
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-09       Impact factor: 4.310

10.  Hydrogen Sulfide Epigenetically Attenuates Homocysteine-Induced Mitochondrial Toxicity Mediated Through NMDA Receptor in Mouse Brain Endothelial (bEnd3) Cells.

Authors:  Pradip K Kamat; Anuradha Kalani; Suresh C Tyagi; Neetu Tyagi
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.